Neuropathy Cream

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. It is intended for use in patients experiencing discomfort due to various conditions affecting musculoskeletal health.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply the medication to the affected area no more than 3 to 4 times daily. For children under 12 years of age, it is recommended to consult a physician prior to use.

The application should be made directly to the affected area, ensuring that the dosage does not exceed the specified frequency.

Contraindications

The product is contraindicated for use on wound or damaged skin due to the potential for irritation and delayed healing. Contact with eyes or mucous membranes should be avoided to prevent adverse reactions. Additionally, tight bandaging is contraindicated as it may lead to compromised circulation and increased risk of skin irritation.

Warnings and Precautions

This product is intended for external use only. It is contraindicated for application on broken skin, wounds, or irritated skin. Healthcare professionals should advise patients to avoid contact with the eyes and mucous membranes during use. Additionally, it is important to instruct patients not to bandage the treated area tightly or apply heat to it, as these actions may exacerbate adverse effects.

Patients should be closely monitored for any signs of worsening conditions or persistent symptoms lasting more than 7 days. If redness or irritation develops, it is imperative to discontinue use and seek medical advice.

To ensure safety, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if redness or irritation develops. Additionally, if symptoms clear up and then recur within a few days, it is recommended that patients seek medical advice. These precautions are essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Neuropathy Cream (menthol cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information regarding the use of Neuropathy Cream in pregnant patients, including safety concerns, dosage modifications, or special precautions during pregnancy. Healthcare professionals should consider the lack of data when prescribing this medication to women of childbearing potential and weigh the potential risks versus benefits. It is advisable to exercise caution and discuss alternative treatment options with patients who are pregnant or planning to become pregnant.

Lactation

The safety of this product has not been established in nursing mothers. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should only be applied to intact skin and not on wounds or damaged skin.

Patients should be instructed to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, they should be made aware that if symptoms clear up and then recur within a few days, they should also stop using the product and seek medical advice.

While using this product, patients must be cautioned against allowing it to come into contact with their eyes or mucous membranes. Furthermore, they should be advised not to bandage the area tightly after application to ensure proper use and minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from direct sunlight and moisture. To ensure safety, the product must be kept out of reach of children. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults and children aged 12 years and older. For children under 12 years of age, it is advised to consult a doctor regarding the appropriate use.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Neuropathy Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)